Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The 2024 ASCO Annual Meeting will be a unique and unparalleled opportunity to connect with one of the largest, most diverse audiences in global cancer care, highlighting the latest innovations in cancer research and education. We're excited to bring you the latest updates in oncology live from Chicago, IL. Stay tuned for expert interviews, podcasts, roundtable discussions, and more..
View all videos

ASCO 2024

31 May–04 June 2024 | Chicago, IL
VJOncology avatar

VJ Oncology

@VJOncology ·
November 6, 2026 2118735395743490394

November is Gastric and Pancreatic Cancer Awareness Month! 📢

This week's VJOncology podcast brings you highlights in #GastrointestinalCancer from #ESMO26, featuring @FilippoPietran4, Hiroya Taniguchi, Zev Wainberg, @LorenzaRimassa, and @david_tougeron, as they discuss trials

Reply on Twitter 2118735395743490394 Retweet on Twitter 2118735395743490394 2 Like on Twitter 2118735395743490394 5 Twitter 2118735395743490394
VJOncology avatar

VJ Oncology

@VJOncology ·
November 6, 2026 2118674883580223977

For #GastricCancer Awareness Month, Yelena Janjigian discusses first-line HER2 strategies in gastric cancer, including investigational HLX-22 + trastuzumab.

▶️ Watch here: https://ow.ly/JaJ45103ZVw

@YJanjigianMD #gism #oncology #StomachCancerAwarenessMonth #ASCO26

Intended for

Image for the Tweet beginning: For #GastricCancer Awareness Month, Yelena Twitter feed image.
Reply on Twitter 2118674883580223977 Retweet on Twitter 2118674883580223977 0 Like on Twitter 2118674883580223977 0 Twitter 2118674883580223977

ASCO 2024

31 May–04 June 2024 | Chicago, IL
The 2024 ASCO Annual Meeting will be a unique and unparalleled opportunity to connect with one of the largest, most diverse audiences in global cancer care, highlighting the latest innovations in cancer research and education. We're excited to bring you the latest updates in oncology live from Chicago, IL. Stay tuned for expert interviews, podcasts, roundtable discussions, and more..
View all videos
VJOncology avatar

VJ Oncology

@VJOncology ·
November 6, 2026 2118735395743490394

November is Gastric and Pancreatic Cancer Awareness Month! 📢

This week's VJOncology podcast brings you highlights in #GastrointestinalCancer from #ESMO26, featuring @FilippoPietran4, Hiroya Taniguchi, Zev Wainberg, @LorenzaRimassa, and @david_tougeron, as they discuss trials

Reply on Twitter 2118735395743490394 Retweet on Twitter 2118735395743490394 2 Like on Twitter 2118735395743490394 5 Twitter 2118735395743490394
VJOncology avatar

VJ Oncology

@VJOncology ·
November 6, 2026 2118674883580223977

For #GastricCancer Awareness Month, Yelena Janjigian discusses first-line HER2 strategies in gastric cancer, including investigational HLX-22 + trastuzumab.

▶️ Watch here: https://ow.ly/JaJ45103ZVw

@YJanjigianMD #gism #oncology #StomachCancerAwarenessMonth #ASCO26

Intended for

Image for the Tweet beginning: For #GastricCancer Awareness Month, Yelena Twitter feed image.
Reply on Twitter 2118674883580223977 Retweet on Twitter 2118674883580223977 0 Like on Twitter 2118674883580223977 0 Twitter 2118674883580223977

Latest videos from ASCO 2024!

View all
0:44
PALOMA-3 results: subcutaneous amivantamab + lazertinib in NSCLC could replace IV formulation
Natasha Leighl • 1 Jun 2024
0:40
ASCO 2024: key updates in gastric, colorectal, and hepatocellular cancer treatments
Ian Chau • 1 Jun 2024
2:55
Melanoma trials at ASCO 2024: KEYMAKER-U02A, IMC-F106 and SC-682
Meredith McKean • 2 Jun 2024
1:41
postMONARCH: abemaciclib with fulvestrant in pretreated HR+/HER2- breast cancer
Kevin Kalinsky • 2 Jun 2024

Breast Cancer

View all
1:58
Impact of CDK4/6 inhibitors on HR-positive, HER2-negative advanced breast cancer
Claudio Vernieri • 2 Aug 2024
0:42
AI advancements at ASCO 2024: transformative impact on cancer diagnosis, treatment, & research
Ravi Bharat Parikh • 1 Aug 2024

Lung Cancer

View all
0:42
AI advancements at ASCO 2024: transformative impact on cancer diagnosis, treatment, & research
Ravi Bharat Parikh • 1 Aug 2024
1:40
Highlights in lung cancer from ASCO 2024
Nicolas Girard • 1 Jul 2024

GI Cancer

View all
0:47
Phase II GIANT trial insights: managing older adults with metastatic pancreatic cancer
Efrat Dotan • 2 Jun 2024
0:49
Challenges in managing vulnerable older adults with newly diagnosed metastatic PDAC
Efrat Dotan • 2 Jun 2024

GU Cancer

View all
0:29
Key findings from Phase I/II Study: fractionated Lu-177 PSMA therapy shows safety and promise
Scott Tagawa • 3 Jun 2024
2:02
Dose-intense 177Lu-PSMA-617 regimen for mCRPC: promising efficacy and manageable toxicity
Scott Tagawa • 3 Jun 2024

Expert interviews with the following speakers and more...

Thomas Powles
MBBS, MRCP, MD
Barts Cancer Institute
Erika Hamilton
MD
Sarah Cannon Cancer Center
Hope Rugo
MD
City of Hope Comprehensive Cancer Center
Arlene Siefker-Radtke
MD
MD Anderson Cancer Center
Melissa Johnson
MD
Sarah Cannon Research Institute
Georgina Long
BSc, PhD, MBBS, FRACP, FAHMS
The University of Sydney
Sara Tolaney
MD, MPH
Dana Farber Cancer Institute

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals